Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-11

Clinical Trial Update: Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria [Phase 3]

View source ↗

Summary

This Phase III study investigates cetirizine hydrochloride injection for acute urticaria and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine Hydrochloride Injection (cetirizine hydrochloride injection)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Acute Urticaria | Phase 3 | Status: RECRUITING